𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Occult hepatitis B virus infection in patients with autoimmune liver diseases

✍ Scribed by Sarah P. Georgiadou; Kalliopi Zachou; Christos Liaskos; Stella Gabeta; Eirini I. Rigopoulou; George N. Dalekos

Book ID
111237988
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
185 KB
Volume
29
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Occult hepatitis C virus infection in Ir
Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease
✍ Farah Bokharaei-Salim; Hossein Keyvani; Seyed Hamid Reza Monavari; Seyed Moayed πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

## Abstract The diagnosis of cryptogenic liver disease is made when after extensive evaluations, recognizable etiologies of chronic liver disease are excluded. In this study, the presence of hepatitis C virus (HCV) RNA was tested in peripheral blood mononuclear cells (PBMCs) taken from Iranian pati

Distribution of hepatitis B virus in the
Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection
✍ Elena RodrΓ­guez-IΓ±igo; Luisa Mariscal; Javier BartolomΓ©; Inmaculada Castillo; Cr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 487 KB πŸ‘ 2 views

## Abstract Although occult hepatitis B virus (HBV) infection (HBV‐DNA in serum in the absence of hepatitis B surface antigen [HBsAg]) is common in chronic hepatitis C, its characteristics are not well known. In this work, the presence of HBV‐DNA (by polymerase chain reaction; PCR) and its distribu

Hepatitis B virus infection in patients
Hepatitis B virus infection in patients with idiopathic liver disease
✍ T. Jake Liang; Yaacov Baruch; Edna Ben-Porath; Rafael Enat; Lucyna Bassan; Nancy πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 951 KB

We studied 67 HBsAg-negative Israeli patients (36 negative for all HBV serological markers as group 1 and 31 positive for antibodies to H B s and HBc as group 2) with chronic liver disease and cirrhosis of unknown origin using a rapid, sensitive and specific assay for the detection of low levels of